Tokyo Tape
Sign in
← Nihon Chouzai

Quarterly report · Q2

3341.TEDINET S100S9Q4
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥166.3bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥313.3bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥152.3bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥3.4bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥2.8bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥3.4bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥7.7bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.8bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥3.4bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥2.9bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥1.7bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.5bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.6bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.7bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥1.6bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥193.5bnat 2023-09-30Cons.Assets
Total assets¥185.3bnat 2023-03-31Cons.Assets
Total assets¥187.6bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥135.6bnat 2023-09-30Cons.Liabilities
Total liabilities¥128.8bnat 2023-03-31Cons.Liabilities
Net assets / equity¥57.9bnat 2023-09-30Cons.Net assets
Net assets / equity¥56.5bnat 2023-03-31Cons.Net assets
Net assets / equity¥54.0bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥22.2bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥23.8bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥22.2bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥23.8bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥21.5bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥25.5bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥11.9bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥7.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥8.0bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥7.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥5.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥713m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥2.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥58.442023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥36.382023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥148.922022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥53.662022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥40.622022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio29.9%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio30.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio28.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥6.7bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥6.7bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥3.5bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥147.6bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥147.6bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥6.0bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥4.9bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥4.9bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥14m
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥698m
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥20.5bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥13.8bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥6.7bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥167m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥173.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥166.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥6.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥6.9bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥7.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥7.0bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥3.3bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥136.2bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥136.2bn
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1m
jpcrp040300-q2r_E05422-000Dispensing Pharmacy Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥6.0bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥4.0bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥4.0bn
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥9m
jpcrp040300-q2r_E05422-000Medical Professional Staffing And Placement Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥500m
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥19.2bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥12.2bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥7.0bn
jpcrp040300-q2r_E05422-000Pharmaceutical Manufacturing And Sales Businessreportable segmentsegment profit2022-04-01 → 2022-09-30−¥396m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥159.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥152.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥7.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥6.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 513
ItemContextValueUnit
Work in processPrior1YearInstant1742000000JPY
Work in processCurrentQuarterInstant1698000000JPY
Raw materials and suppliesPrior1YearInstant6021000000JPY
Raw materials and suppliesCurrentQuarterInstant6023000000JPY
Other caPrior1YearInstant4022000000JPY
Other caCurrentQuarterInstant4468000000JPY
Allowance for doubtful accounts caPrior1YearInstant-6000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-6000000JPY
Current assetsPrior1YearInstant85720000000JPY
Current assetsCurrentQuarterInstant89181000000JPY
Buildings and structures netPrior1YearInstant28361000000JPY
Buildings and structures netCurrentQuarterInstant29098000000JPY
LandPrior1YearInstant13377000000JPY
LandCurrentQuarterInstant13346000000JPY
Construction in progressPrior1YearInstant1828000000JPY
Construction in progressCurrentQuarterInstant1745000000JPY
Other net ppePrior1YearInstant17867000000JPY
Other net ppeCurrentQuarterInstant17452000000JPY
Property plant and equipmentPrior1YearInstant61435000000JPY
Property plant and equipmentCurrentQuarterInstant61643000000JPY
GoodwillPrior1YearInstant14195000000JPY
GoodwillCurrentQuarterInstant13700000000JPY
Other iaPrior1YearInstant5377000000JPY
Other iaCurrentQuarterInstant6866000000JPY
Intangible assetsPrior1YearInstant19573000000JPY
Intangible assetsCurrentQuarterInstant20566000000JPY
Investment securitiesPrior1YearInstant16000000JPY
Investment securitiesCurrentQuarterInstant16000000JPY
Lease and guarantee depositsPrior1YearInstant9160000000JPY
Lease and guarantee depositsCurrentQuarterInstant11652000000JPY
Other ioaPrior1YearInstant9391000000JPY
Other ioaCurrentQuarterInstant10393000000JPY
Investments and other assetsPrior1YearInstant18568000000JPY
Investments and other assetsCurrentQuarterInstant22062000000JPY
Noncurrent assetsPrior1YearInstant99576000000JPY
Noncurrent assetsCurrentQuarterInstant104272000000JPY
AssetsPrior1YearInstant185297000000JPY
AssetsCurrentQuarterInstant193453000000JPY
Accounts payable tradePrior1YearInstant47916000000JPY
Accounts payable tradeCurrentQuarterInstant57136000000JPY
Electronically recorded obligations operating clPrior1YearInstant1476000000JPY
Electronically recorded obligations operating clCurrentQuarterInstant2176000000JPY
Short term loans payablePrior1YearInstant2000000000JPY
Short term loans payableCurrentQuarterInstant－JPY
Current portion of long term loans payablePrior1YearInstant10390000000JPY
Current portion of long term loans payableCurrentQuarterInstant10800000000JPY
Income taxes payablePrior1YearInstant2640000000JPY
Income taxes payableCurrentQuarterInstant1961000000JPY
Provision for bonusesPrior1YearInstant3892000000JPY
Provision for bonusesCurrentQuarterInstant4445000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass